HopeStage
Back to all studies
CompletedNCT01301183

Hormone Treatment and Bone Development in Teenagers With Anorexia

About this titleRead the official source — NCT01301183
Medication studyAges 14–22United StatesEating disorders
The study in practice

Understand this study

Who was this study for?

Listed age limits: 14 years to 22 years.

Listed locations
BostonSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: February 2011
Recruitment status
Completed
Enrollment listed in the registry
75
Sponsor
Massachusetts General Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 14 Years to 22 Years
Official registry ID
NCT01301183
Official title
Show the full official title

Effects of Anorexia Nervosa on Peak Bone Mass

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Boston

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including RhIGF-1 with transdermal 17-beta estradiol and Placebo and transdermal 17-beta estradiol.

Who was this study for?

Listed age limits: 14 years to 22 years.

Want to explore more studies?

Explore studies